This discrepancy in the findings may be because we focused only on TP53 mutations from exons 5 to 8, consisting of the DNA-binding region, by direct sequencing of tumor tissues, which could have resulted in a low yield compared to that with next-generation sequencing of plasma samples [33]. This evidence concerns the gene TP53 and neoplasm.